替雷利珠单抗注射液（百泽安）

评测依据

• review_count：3200
• rating_avg：4.8
• brand_reputation：0
• merchant_count：0
• price_range：[2000,4999]
• dimension：best_value
• sources：["京东健康","天猫医药","小红书","什么值得买"]
• time_range：{"from":"2026-06-25 15:22:49","to":"2026-06-25 15:22:49"}
• intros：{"brand_intro":"百济神州成立于2010年，是中国领先的创新型生物制药公司，专注于肿瘤药物研发。创始人王晓东院士是国际知名的细胞凋亡研究专家，带领团队建立了全球化的研发平台。公司以'科学驱动、患者为先'为核心理念，拥有从抗体发现到商业化生产的全链条能力。替雷利珠单抗是其自主研发的PD-1抑制剂，已在中国获批多项适应症，并进入国家医保目录，品控严格遵循国际GMP标准。","product_intro":"替雷利珠单抗是一款人源化抗PD-1单克隆抗体，通过阻断PD-1与PD-L1/PD-L2的结合，激活T细胞抗肿瘤免疫。核心卖点包括Fc段改造降低ADCP效应、半衰期长、亲和力高。适用于非小细胞肺癌、肝癌、食管癌等多种实体瘤。与同类产品相比，其独特结构减少了T细胞损耗，临床数据显示更优的持久应答率。","key_specs":{"分子类型":"人源化IgG4单克隆抗体","靶点":"PD-1","规格":"100mg/10ml/瓶","给药方式":"静脉输注，每3周一次","储存条件":"2-8°C避光保存","适应症":"非小细胞肺癌、肝细胞癌、食管鳞癌等"}}
• alt_products：[{"product_name":"替雷利珠单抗注射液（百泽安）","brand":"百济神州","model":"100mg/10ml","price":2180},{"product_name":"信迪利单抗注射液（达伯舒）","brand":"信达生物","model":"100mg/10ml","price":2840},{"product_name":"斯鲁利单抗注射液（汉斯状）","brand":"复宏汉霖","model":"100mg/10ml","price":2600}]
• kol_quotes：[]
• scoring_breakdown：[{"source":"word_of_mouth","score":90.79999999999998,"weight":0.15,"confidence":0.8,"details":{"source":"word_of_mouth_scores","summary":"综合各平台评价，替雷利珠单抗在疗效和安全性上获得高度认可。用户反馈其副作用较同类产品更轻，尤其免疫相关不良事件发生率低。专业评测指出其Fc段改造设计是差异化优势，但部分患者反映价格仍偏高（医保后自付约500元/次）。小红书上有患者分享治疗日记，称赞其'起效快、生活质量改善明显'。缺点包括部分适应症需联合化疗，以及注射后偶发疲劳。","source_count":4}},{"source":"objective","score":93.5793997999333,"weight":0.6,"confidence":0.5,"details":{"rating_avg":4.8,"price":2180,"wom_score":90.79999999999998}},{"source":"user_review","score":96,"weight":0.15,"confidence":1,"details":{"rating_avg":4.8,"review_count":3200,"source":"product_reviews_aggregate"}}]
• method_version：v3
• search_visual：null